InMed

We do things that make tomorrows headlines.

Catch all the latest news about and goings on at InMed
AI Studio right here

Adjunctive Brain Volume Quantification Tool for MRI

Providing automated brain volume calculations based on MRI images, NeuroShield’s artificial intelligence (AI)-powered technology may help facilitate treatment for neurodegenerative…

New AI-powered Tool automatically Quantifies

NeuroShield takes 3D MR images as inputs and automatically calculates brain volumes that can assist physicians in devising treatment plans for patients with…

InMed AI Receives FDA 510(k) clearance for NeuroShield™

AI-powered NeuroShield automatically quantifies brain volumes using MRI data – the first of its kind with the capability to provide ethnicity-specific reference ranges…

PMX, AI healthcare company partners with Inmed 

PMX has partnered with Inmed Prognostics to provide full-body assessment AI analytic software from body-MRI screening. This AI tool has been used to screen the…

InMed AI secures FDA 510(k) clearance for NeuroShield

Data analytics company InMed AI has received US Food and Drug Administration (FDA) 510(k) clearance for NeuroShield, an artificial intelligence (AI) powered tool that uses 3D MR…

InMed.AI gets FDA nod for NeuroShield

Pune, India-based InMed.AI (InMed Prognostics) has received 510(k) clearance from the U.S. Food and Drug Administration for its NeuroShield technology for use in MRI…

In-Med launches AI Tool to reduce mortality in neurotrauma

In-Med AI on Monday announced the launch of their new product, Neuroshield CT TBI. According to the company’s press statement, Neuroshield CT is an AI based neurotrauma…

In-Med raises $2.13 M to expand AI-based image processing

In-Med Prognostics, an artificial intelligence (AI) startup with expertise in multi-modal data and image processing, has raised $2.13 million led by Exxora with participation from prominent…

InMed AI Receives FDA 510(k) clearance for NeuroShield™

PRNewswire/ — InMed.AI (InMed Prognostics Inc.), a pioneer in AI-driven predictive analytics using multi-modal data including text, signal, and image (US Patent No.11263749) and…

Neuroshield CT empowers radiologists, neurologists

This state-of-the-art technology empowers radiologists, neurologists, and neurosurgeons with accurate data, facilitating rapid, informed decision-making around workflow prioritization…

Neuroshield CT, AI based neurotrauma screening tool

Pune, February 6, 2024: In-Med AI announces the launch of their new product, “Neuroshield CT TBI.” Neuroshield CT is an AI based neurotrauma screening and…

Neuroshield CT-TBI, an AI-enabled tool launched 

Built on extensive imaging data, NeuroShield CT will aid neuro-critical teams in identifying and quantifying pathologies related to Traumatic Brain Injury (TBI) cases. Leveraging AI…

In-Med Ai launches revolutionary “Neuroshield CT”

In-Med AI announces the launch of their new product, “Neuroshield CT TBI.” Neuroshield CT is an AI based neurotrauma screening and quantification workflow optimization…

InMed in Media

  • NeuroShield, InMed AI's FDA-cleared AI, redefines neurology care, setting global standards with precision and automated MRI analysis.

  • Pune-based startup InMed Prognostics Inc. has secured the US Food and Drug Administration (FDA) 510(k) clearance for NeuroShield™

  • InMed AI Tool Reduces Neurotrauma Mortality Rates

  • InMed AI has received US Food and Drug Administration (FDA) 510(k) clearance for NeuroShield, an artificial intelligence (AI) powered tool

  • In-Med Prognostics raises $2.13 Mn in the new round

We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.
Accept